• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

频繁的Bcl-2表达对肾细胞癌患者预后较好的影响。

Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients.

作者信息

Itoi T, Yamana K, Bilim V, Takahashi K, Tomita F

机构信息

Division of Molecular Oncology, Department of Signal Transduction Research, Graduate School of Medical and Dental Sciences, Niigata University, Asahimachi 1-757, Niigata 951-8510, Japan.

出版信息

Br J Cancer. 2004 Jan 12;90(1):200-5. doi: 10.1038/sj.bjc.6601454.

DOI:10.1038/sj.bjc.6601454
PMID:14710230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2395310/
Abstract

Previously, we reported that Bcl-2 was frequently expressed in renal cell carcinoma (RCC) specimens, but p53 mutation was a rare event. However, it was unclear whether Bcl-2 positivity was associated with the clinicopathological characteristics and prognosis in RCC. Therefore, we investigated the expression of Bcl-2 protein and its roles in 101 RCC specimens. In addition, the proliferation index (PI), apoptotic index (AI), caspase-3 and p53 expression were examined. The immunohistochemical method was applied for Bcl-2, caspase-3 and p53 protein expression. To investigate the proliferation activity and apoptosis of tumour cells, PI and AI were calculated based on Ki-67 and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling (TUNEL)-positive cells, respectively. Bcl-2 expression was detected in 72 out of 101 (71.3%) specimens. Bcl-2 positivity was inversely correlated with PI (P<0.0001) and AI (P=0.0074). Furthermore, Bcl-2 positivity was significantly correlated with better survival (P=0.0014), and was associated with lower stage (P=0.0301) and grade (P=0.0020). In RCC, frequent Bcl-2 expression was correlated with favourable character without higher PI and AI. Thus, Bcl-2 expression might be applied as a novel predictor of better prognosis in RCC patients.

摘要

此前,我们报道过Bcl-2在肾细胞癌(RCC)标本中经常表达,但p53突变却是罕见事件。然而,尚不清楚Bcl-2阳性是否与RCC的临床病理特征及预后相关。因此,我们研究了101例RCC标本中Bcl-2蛋白的表达及其作用。此外,还检测了增殖指数(PI)、凋亡指数(AI)、半胱天冬酶-3和p53的表达。采用免疫组化方法检测Bcl-2、半胱天冬酶-3和p53蛋白的表达。为了研究肿瘤细胞的增殖活性和凋亡情况,分别基于Ki-67和末端脱氧核苷酸转移酶介导的dUTP-生物素缺口末端标记法(TUNEL)阳性细胞计算PI和AI。在101例标本中有72例(71.3%)检测到Bcl-2表达。Bcl-2阳性与PI(P<0.0001)和AI(P=0.0074)呈负相关。此外,Bcl-2阳性与更好的生存率显著相关(P=0.0014),并与较低分期(P=0.0301)和分级(P=0.0020)相关。在RCC中,频繁的Bcl-2表达与良好特征相关,且PI和AI不高。因此,Bcl-2表达可能作为RCC患者预后较好的一种新的预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4685/2395310/73ac067b292f/90-6601454f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4685/2395310/7bd68bffe3a1/90-6601454f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4685/2395310/52a3eb4d87ef/90-6601454f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4685/2395310/73ac067b292f/90-6601454f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4685/2395310/7bd68bffe3a1/90-6601454f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4685/2395310/52a3eb4d87ef/90-6601454f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4685/2395310/73ac067b292f/90-6601454f3.jpg

相似文献

1
Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients.频繁的Bcl-2表达对肾细胞癌患者预后较好的影响。
Br J Cancer. 2004 Jan 12;90(1):200-5. doi: 10.1038/sj.bjc.6601454.
2
The relationship of expression of bcl-2, p53, and proliferating cell nuclear antigen (PCNA) to cell proliferation and apoptosis in renal cell carcinoma.肾细胞癌中bcl-2、p53和增殖细胞核抗原(PCNA)的表达与细胞增殖和凋亡的关系。
J Huazhong Univ Sci Technolog Med Sci. 2004;24(4):354-7. doi: 10.1007/BF02861866.
3
Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma.肾细胞癌中细胞增殖、凋亡与BCL-2表达情况
Urology. 2000 Sep 1;56(3):510-5. doi: 10.1016/s0090-4295(00)00645-2.
4
[Apoptosis of renal cell carcinoma and apoptotic related genes bcl-2 and bax].[肾细胞癌的凋亡及凋亡相关基因bcl-2和bax]
Zhonghua Wai Ke Za Zhi. 1998 Jun;36(6):373-5.
5
Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome.肾细胞癌临床样本中与化疗耐药、增殖及凋亡相关基因的表达及其与临床结局的相关性
Anticancer Res. 2002 Jan-Feb;22(1A):121-8.
6
Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.传统型(透明细胞)肾细胞癌转移灶的bcl-2表达高于高危原发性肿瘤。
Urol Oncol. 2003 May-Jun;21(3):179-84. doi: 10.1016/s1078-1439(02)00236-3.
7
Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.p53和bcl-2在原发性局限性肾细胞癌中的表达:无预后意义的证据
Anticancer Res. 1996 Nov-Dec;16(6B):3807-11.
8
[Cellular apoptosis, proliferation and bcl-2 Bax expression in colorectal carcinoma and their association with tumor prognosis].[结直肠癌中的细胞凋亡、增殖及bcl-2、Bax表达及其与肿瘤预后的关系]
Zhonghua Wai Ke Za Zhi. 1998 Oct;36(10):614-6, 120.
9
Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth.PTEN在肾细胞癌中的表达及其与肿瘤行为和生长的关系。
J Surg Oncol. 2003 Nov;84(3):166-72. doi: 10.1002/jso.10302.
10
Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas.肾细胞癌中细胞凋亡及Bcl-2、Bcl-XL和Bax的表达
Cancer Invest. 2002;20(3):324-32. doi: 10.1081/cnv-120001177.

引用本文的文献

1
Radiogenomic correlation of hypoxia-related biomarkers in clear cell renal cell carcinoma.透明细胞肾细胞癌中缺氧相关生物标志物的放射基因组相关性
J Cancer Res Clin Oncol. 2025 Jun 12;151(6):186. doi: 10.1007/s00432-025-06240-8.
2
Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to Immune-Checkpoint Inhibitors-Based Treatments in Clear-Cell Renal Carcinoma.透明细胞肾细胞癌中与基于免疫检查点抑制剂治疗反应相关的炎症和免疫基因表达模式及机器学习方法
Cancers (Basel). 2023 Nov 29;15(23):5637. doi: 10.3390/cancers15235637.
3
Molecular Biomarkers of Bladder Cancer: A Mini-Review.

本文引用的文献

1
Primary apoptosis as a prognostic index for the classification of metastatic renal cell carcinoma.原发性凋亡作为转移性肾细胞癌分类的预后指标。
J Urol. 2002 Aug;168(2):460-4.
2
Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci.Bcl-2表达抑制肝癌发生并延缓增殖灶的发展。
Am J Pathol. 2002 May;160(5):1555-60. doi: 10.1016/S0002-9440(10)61101-7.
3
Expression of apoptosis-regulating proteins p53, Bcl-2, and Bax in primary resected esophageal squamous cell carcinoma.凋亡调节蛋白p53、Bcl-2和Bax在原发性切除食管鳞状细胞癌中的表达
膀胱癌的分子生物标志物:小型综述。
Physiol Res. 2023 Oct 27;72(S3):S247-S256. doi: 10.33549/physiolres.935187.
4
can predict the poor prognosis of clear cell renal cell carcinoma.可预测透明细胞肾细胞癌的不良预后。
Front Oncol. 2022 Aug 16;12:882888. doi: 10.3389/fonc.2022.882888. eCollection 2022.
5
A Mesenchymal Tumor Cell State Confers Increased Dependency on the BCL-XL Antiapoptotic Protein in Kidney Cancer.间质肿瘤细胞状态赋予肾癌细胞对 BCL-XL 抗凋亡蛋白的依赖性增加。
Clin Cancer Res. 2022 Nov 1;28(21):4689-4701. doi: 10.1158/1078-0432.CCR-22-0669.
6
Assessment of the prognostic value of in clear cell renal cell carcinoma: a bioinformatics analysis.评估[具体内容]在透明细胞肾细胞癌中的预后价值:一项生物信息学分析。 (你原文中“of”后面缺少具体内容)
Transl Androl Urol. 2022 Apr;11(4):509-518. doi: 10.21037/tau-22-161.
7
Expression levels of sonic hedgehog pathway genes and their targets are upregulated in early clear cell renal cell carcinoma.早期透明细胞肾细胞癌中 sonic hedgehog 通路基因及其靶基因的表达水平上调。
Int J Mol Med. 2022 May;49(5). doi: 10.3892/ijmm.2022.5114. Epub 2022 Mar 10.
8
The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review.PI3K/AKT信号通路在癌症发生和耐药中的致病作用:最新综述
Cancers (Basel). 2021 Aug 5;13(16):3949. doi: 10.3390/cancers13163949.
9
Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌预后表达标志物综述
Front Oncol. 2021 Apr 28;11:643065. doi: 10.3389/fonc.2021.643065. eCollection 2021.
10
Synergistic Effects of TW-37 and ABT-263 on Renal Cell Carcinoma Cells.TW-37与ABT-263对肾癌细胞的协同作用
Cancer Manag Res. 2021 Feb 3;13:953-963. doi: 10.2147/CMAR.S265788. eCollection 2021.
Neoplasma. 2001;48(6):483-8.
4
Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.p53、mdm2和bcl-2蛋白在肾细胞癌中的临床意义
Urology. 2002 Apr;59(4):615-20. doi: 10.1016/s0090-4295(01)01601-6.
5
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.bcl-2、bax、bcl-xL、bag-1、fas和fasL对晚期乳腺癌化疗反应的预测价值。
Clin Cancer Res. 2002 Mar;8(3):811-6.
6
Apoptosis as an independent prognostic indicator in squamous cell carcinoma of the esophagus.细胞凋亡作为食管鳞状细胞癌的独立预后指标。
Pathol Int. 2001 Jul;51(7):498-503. doi: 10.1046/j.1440-1827.2001.01234.x.
7
Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?凋亡基因bcl-2和bax的表达能否预测淋巴结阴性乳腺癌患者的生存率及对化疗的反应?
J Surg Res. 2001 Aug;99(2):161-8. doi: 10.1006/jsre.2001.6084.
8
Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma.肾细胞癌中细胞增殖、凋亡与BCL-2表达情况
Urology. 2000 Sep 1;56(3):510-5. doi: 10.1016/s0090-4295(00)00645-2.
9
High levels of apoptosis are associated with improved survival in non-small cell lung cancer.高水平的细胞凋亡与非小细胞肺癌患者生存率的提高相关。
Anticancer Res. 2000 May-Jun;20(3B):2123-8.
10
Caspase involved synergistic cytotoxicity of bcl-2 antisense oligonucleotides and adriamycin on transitional cell cancer cells.半胱天冬酶参与bcl-2反义寡核苷酸与阿霉素对移行细胞癌细胞的协同细胞毒性作用。
Cancer Lett. 2000 Jul 31;155(2):191-8. doi: 10.1016/s0304-3835(00)00428-6.